||EPS - Basic
||Market Cap (m)
RWS Share Discussion Threads
Showing 551 to 573 of 575 messages
|been here before ... what's changed?
When you owe shares in a quality company, time is your friend|
|lifeless and a relentless move south without any sign of reversing?|
|Dunno, jg.. I just reported the link.
Paucity of real data, as you observed earlier.
I agree with your opinion that it is a matter of trust in the management.
I have only returned to watching RWS after the recent share price drift and have bought a first holding, so I haven't had chance to gain the confidence you have.
|Google Luz Inc.
From the website, under services overview.
Capacity and Scalability
Over 1,500 life science linguists, editors/proofreaders, desktop publishing specialists, and localization engineers|
|surely they haven't lost 80 staff, apad? LUZ has been growing quickly according to its revenue numbers, so very unlikely staff numbers are reducing. Could some people be contractors and one number (100) is of permanents only, the other (180)includes temporary and contracting staff? The revenue number you quote seems about right - RWS said LUZ had revenue of 23.7m in 2015 (and 29.2 in 2016, from 21.2 in 2014).
As I said previously, I wished RWS released more info on LUZ. We'll know more when we say subsequent earnings releases. In the interim, we just have to trust mgmt. to have got this right. I do, but I'd still like to know more!|
|head count in rns is 100, I believe.
|Spoke too soon!|
|Looks like 25m revenue in 2016.
Glassdoor reports the exodus of experienced staff in 2016. New directors appointed in 2016.
San Francisco, CA
|but I'm already here, Phillis|
well better to keep the nutters away dont you think?|
|agreed Phillis. I've held for over a decade too, and plan to hold for another one! For an outstanding company, never ceases to amaze that this is such a quiet board!|
|this is a wonderful stock and i have been a fan for over a decade
looking forward to a trading update in early April
last comment from the AGM RNS
"As a result, profits for the first quarter were comfortably ahead of management's expectations"
The share price is a bit flat following the placement activity so a good time for some top up
IHT free in an ISA to boot|
|And Telegraph's Questor too.|
|Tipped in The Times today - 'strong track record on growth and acquisitions'.|
|thanks for posting Andrew|
|Bought into these last night- technically looking very strong|
|OK with me too Andrew|
|Well, there we have it from the horses mouth (apologies to AB who I have met and has only two legs). Whatever advantages a full listing might appear to confer, it's clear to me that one of the attractions of companies like RWS is that management and shareholders interests are perfectly aligned when it comes to IHT.|
|Hi jg and alter ego, thanks for your replies. Seems a shame if they don't fully list, perhaps a bit of downside from having a significant holder who in theory should be working in all shareholder interests albeit I would gather lots are happy with how well their investment has done here and will be keen to keep management on board. It would hopefully expand the amount of information we get too. Hey ho.|
|I confirm that I and more than 20% of our other shareholders are very interested in IHT/BPR relief, so a move to the Full List is highly unlikely in the near term.We like being a Top 10 Aim listed company.|
|Stockopedia's Graham Neary likes the results -
RWS Holdings (LON:RWS)
Share price: 354p (+4.5%)
No. shares: 215.8m
Market cap: £764m
Acquisition and Placing
A strong statement to open today's news:
"Since [30 September 2016], the Group has traded strongly with underlying growth bolstered by favourable currency movements. We are achieving meaningful new client wins in both of our core activities, intellectual property and Life Sciences and increased levels of business from a number of our established clients. As a result, profits for the first quarter were comfortably ahead of management's expectations.
I must admit that I haven't studied this company before, but it sounds quite interesting:
RWS Group is internationally renowned for providing high-quality translation, intellectual property and language support services, which we deliver through our in-house translators, searchers and technical experts.
Excuse my ramblings, but shouldn't IP translation and search be secular growth industries in today's economy? RWS has had 13 successive years of growth in sales & profits - is that a mark of their individual brilliance as a company, or is it mostly to do with growth trends in their markets? I'd be curious to learn more.
Anyway, today's $82.5 million acquisition is for the life sciences division:
The Acquisition strengthens the Group's leading position in global Life Sciences both in the US and Europe, building upon and complementing the October 2015 acquisition of Corporate Translations Inc. ("CTi") and creating a full service offering. It also enhances the platform for expansion into Asia, building on the existing Chinese and Japanese presence of other RWS divisions.
The Acquisition also brings strong cross-selling opportunities through enhanced exposure to the important West Coast patent market and potentially bringing new clients to the wider Group. It also provides diversification to the Group (including currency) and further visibility across the value chain.
It's good to see a combination of funding sources being used: the placing, cash and a bank term loan, with most of it coming the placing (worth $50 million at GBPUSD = 1.25).
The Value Rank is not a big fan of this stock, at a PE ratio of 27x. Without going into it in any more detail, it wouldn't surprise me if this stock was in fact decent value here - specialist, niche services with huge growth momentum behind them are often worth paying up for.|
|regarding a full listing, I doubt this is likely. From memory, I believe Andrew Brode has 2(?) daughters and clearly it is in his interest and theirs that his shareholding should be passed on without being subject to IHT. As an AIM stock, it would be exempt whereas a full listing would not. Just my opinion but family firms are often kept on AIM for this reason. In fact, LTHM was once a fully listed company but some years ago moved to AIM. It's no coincidence that the family have a large shareholding IMO.|
yes, I give mgmt benefit of doubt too. Luz was formed in 1994, now has revenue of $29m, so clearly a growing business. Profits growing too - I'd like to understand why the jump last year, I'm sure RWS insiders know (presumably due to business growth - but is some part of it one-off in nature, what prospects for sustained growth at that rate, or something more moderate)?.
I'm just disappointed we weren't offered more detail on the financials. I trust bd and mgmt - I have owned since 2009, and never sold. I just don't why there is understand such limited disclosure on the new acquisition - would be nice to try and understand it a bit more!|